Navigation Links
amfAR Appoints Dr. Annette Sohn as Vice President of Global Initiatives
Date:5/28/2008

Renowned pediatrician will lead AIDS research foundation's international program, including its TREAT Asia initiative

NEW YORK, May 28 /PRNewswire-USNewswire/ -- amfAR, The Foundation for AIDS Research, has appointed Annette Sohn, MD, as vice president for global initiatives and director of TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia), announced Kevin Robert Frost, amfAR's chief executive officer. Dr. Sohn will take up her appointment on September 1, 2008.

Dr. Sohn is a highly regarded pediatrician and researcher with extensive experience treating HIV/AIDS among women and children in Southeast Asia. She is an assistant professor in the Division of Pediatric Infectious Diseases at the University of California, San Francisco (UCSF), and former Vietnam country representative for the UCSF Institute for Global Health.

Dr. Sohn is based in Ho Chi Minh City, where she has directed a pediatric HIV research program in collaboration with Children's Hospital #1 and the Ho Chi Minh City AIDS Committee. Her projects there included studies of diagnostic testing and monitoring in HIV-exposed infants, stigma and discrimination in the context of prevention of mother-to-child transmission, and contraception and reproductive health outcomes of HIV-positive women.

She is a former member of amfAR's TREAT Asia steering committee, pediatric network, and the Pediatric HIV Observational Database working group. Dr. Sohn also is a technical advisor to PEPFAR-Vietnam, assisting in-country programs on coordination, protocols, and capacity building for scaling up their comprehensive pediatric antiretroviral treatment programs.

"I am delighted that Annette Sohn will join amfAR in a leadership capacity," Frost said. "Dr. Sohn brings a unique combination of practical medical experience, cultural understanding, groundbreaking research, and a dedication to amfAR's global efforts to defeat the HIV/AIDS epidemic."

Recently
'/>"/>

SOURCE American Foundation for AIDS Research (amFAR)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
2. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
3. amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Novo Nordisk Appoints New Leader of North American Business
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...n. 8 Press Ganey Associates, Inc.,...ology (PatientFlow), a,leading provider of patien....,The Boston-based company specializes in improvi...tions for patient flow issues such as emergency ro...ed surgeries, and lack of,available ICU and hospi...
(Date:1/7/2009)... the time pancreatic cancer is discovered, it is o...Patrick Swayze) and survival rates are low. Dr. A... in pancreatic, liver and gastrointestinal (GI) ca...reated a groundbreaking team approach to improve c...s for patients. , Morri...
(Date:1/7/2009)...containing health care costs could have the uninte...y, impairing quality and perhaps even increasing c...sicians suggest in a New England Journal of Medic...l economics and psychology, Pamela Hartzband, MD a...ning a monetary value to every aspect of a physici...
(Date:1/7/2009)... 7 Non-profits Medical Tourism Association ( www....th Care City ( www.monterreyciudaddelasalud.com....in America Medical Tourism and Health Tourism Cong...y, Mexico at the Intercontinental Presidente. Mon...medical tourism in Latin America, has several JCI ...
Breaking Medicine News(10 mins):Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2Health News:Cost containment focus could have consequences for health care delivery 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 4
...tential flu pandemic showed that nearly 62 million...ileged nations, could pay// with their life. The... Spanish flu, which wiped out nearly 20 million pe...om the Harvard School of Public Health and the Uni...
... pain are effective, a new review of studies has f...ogical outcomes such as// depression and health-re...experience of pain. “Because this analysis was b...ive than previous reviews, we have the best eviden...
...ient may be forced to undertake treatment in spite... painful radiotherapy. Having beaten the condition...nning over six years, Leah has been confronted by ... to her parents Kathryn and Mark Richards, the att...
...atry published a study which proved that Botox- th...ting wrinkled skin could ease writer’s cramp as we... contractions of the hand, arms or fingers which c...ur during manual work. Some people learn to write ...
Other Medicine News:Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 2Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 3
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/... that predict a high likelihood of relapse in chil...ough the researchers caution that further research...alled IKZF1 or IKAROS, lead to leukemia relaps...r future diagnostic tests to assess the risk of tr...
(Date:1/7/2009)..., OXFORD, England, January 7 ...pany focused on allergy and critical care, today,...ts achieved in 2008 with,its ToleroMune(R) anti-a...patient recruitment for a further phase II clinica...way in Canada, has recruited 120 patients with con...
(Date:1/6/2009)..., ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswire/...ical company focused on diseases of epidemic poten...ndidate for the treatment of tuberculosis (TB), wa...y awarded clinical program contract to Dynport Vac...contract, awarded by the National Institute of All...
(Date:1/5/2009)..., BETHESDA, Md., Jan. 5 /PRNewswire-FirstCal...maceutical company developing novel, proprietary,...on and autoimmune diseases,provides an outlook o... Micromet intends to provide an update on its ...g events: , -- April 12 to 16, 2009: Update...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 1First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 2First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 3Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate 241 To Accelerate Cancer Research 5284 1Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate 241 To Accelerate Cancer Research 5284 2Genaera Corporation Announces First Quarter Financial Results 5280 1Genaera Corporation Announces First Quarter Financial Results 5280 2Genaera Corporation Announces First Quarter Financial Results 5280 3Genaera Corporation Announces First Quarter Financial Results 5280 4Aerospace business leader supreme problem solver 18941 1Aerospace business leader supreme problem solver 18941 2
...lls Isolated from Females Regenerate Skeletal Musc...pril 09, 2007 /PRNewswire/ -- Female stem cells,de...rate skeletal,muscle tissue than male cells, accor...gh of UPMC. , The study, which is being published ...y, is the first ever to report a difference,in reg...
...y and MedImmune to Present Preclinical Data From S...IDGE, Mass. and GAITHERSBURG, Md., April 10, 2007 ... (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) t...with an oral formulation of IPI-504 in non-small,c...pcoming Annual,Meeting of the American Association...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies.
Inquire
Inquire
This remarkable anti-reflux valve is enclosed in a hard plastic housing which prevents the valve from being accidentally held closed when in sitting or reclining positions. The valve is virtually sel
Medicine Products: